TABLE 8.
The surface under the cumulative ranking curve probability ranking.
| Interventions | 2 h (VAS score) | 6 h (VAS score) | 12 h (VAS score) | 24 h (VAS score) | Consumption of analgesics | First analgesic requirement time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUCRA% | Ranking | SUCRA% | Ranking | SUCRA% | Ranking | SUCRA% | Ranking | SUCRA% | Ranking | SUCRA% | Ranking | |
| Acetazolamide | NA | NA | NA | NA | 85.9 | 1 | 82.7 | 2 | NA | NA | NA | NA |
| Bicarbonate | 39.1 | 6 | NA | NA | NA | NA | 96.5 | 1 | NA | NA | NA | NA |
| Bupivacaine | 41.9 | 5 | 74.6 | 2 | 40.7 | 4 | 30.1 | 7 | NA | NA | 68.8 | 2 |
| Dexamethasone | 56.8 | 4 | NA | NA | 79.3 | 2 | 49.7 | 5 | 95.3 | 1 | 81.5 | 1 |
| Levobupivacaine | 83 | 2 | 62 | 3 | 38 | 5 | 57.7 | 4 | 35.4 | 4 | 52.4 | 3 |
| Marcaine | 20.5 | 7 | NA | NA | NA | NA | 33.2 | 6 | NA | NA | NA | NA |
| MgSO4 | NA | NA | 98.4 | 1 | NA | NA | NA | NA | 46.1 | 3 | 0.3 | 5 |
| Ondansetron | 96.4 | 1 | NA | NA | 53.2 | 3 | 28.1 | 8 | NA | NA | NA | NA |
| Placebo | 65.2 | 3 | 55.5 | 4 | 3 | 6 | 74.6 | 3 | 1.9 | 5 | 47.2 | 4 |
| Ropivacaine | NA | NA | NA | NA | NA | NA | NA | NA | 71.3 | 2 | NA | NA |
NA, data Not Available; SUCRA, the surface under the cumulative ranking curve; VAS, visual analog scale.
Bold font indicates that the difference was statistically significant.